Abstract

    Open Access Research Article Article ID: JAMTS-12-162

    Synergistic Inhibition of Glioblastoma Proliferation via Cold-Pressed Allium sativum Nanomicelles: An In Vitro Apoptotic Pathway Analysis

    Chazi A Shawkat*

    Glioblastoma Multiforme (GBM) represents the most aggressive and lethal primary malignant brain tumor in adults, characterized by diffuse parenchymal infiltration, hypervascularity, profound resistance to standard Temozolomide (TMZ) chemotherapy, and extensive molecular heterogeneity. Bioactive organosulfur compounds derived from garlic (Allium sativum), particularly Diallyl Trisulfide (DATS), diallyl disulfide (DADS), and allicin, possess potent antineoplastic properties but are severely limited clinically by rapid volatilization, instability, low aqueous solubility, and insufficient Blood–Brain Barrier (BBB) penetration. In this investigation, cold-pressed Allium sativum lipophilic extracts were encapsulated into self-assembling poly (ethylene glycol)-block-poly (lactic-co-glycolic acid) (PEG-b-PLGA) polymeric nanomicelles (AS-NMs) to enhance intracellular stability and targeted bio-efficacy. Physicochemical characterization revealed monodisperse spherical vesicles (mean hydrodynamic diameter: 82.4 ± 3.8 nm; polydispersity index: 0.114; zeta potential: -18.7 ± 1.5 mV; encapsulation efficiency: 87.3%). Treatment of human glioblastoma models (U87MG, U251, and patient-derived primary glioma stem-like cells GSC-387) demonstrated dose-dependent cytotoxic synergy when AS-NMs were combined with low-dose TMZ, yielding Combination Index (CI) values between 0.38 and 0.54. Mechanistic pathway interrogation verified that AS-NMs trigger intrinsic mitochondrial apoptosis via selective elevation of intracellular reactive oxygen species (ROS), collapse of the mitochondrial membrane potential (ΔΨm), transcriptional and translational upregulation of pro-apoptotic Bax, downregulation of anti-apoptotic Bcl-2 and Mcl-1, cytochrome c release, and sequential cleavage of Caspase-9, Caspase-3, and Poly(ADP-ribose) polymerase (PARP). Concurrent attenuation of the oncogenic PI3K/Akt/mTOR axis, coupled with marked cell cycle arrest at the G2/M checkpoint, indicates that biomimetically engineered phytotherapeutic nanocarriers represent an efficacious adjuvant paradigm against treatment-refractory malignant gliomas.

    Keywords:

    Published on: Nov 11, 2026 Pages: 19-25

    Full Text PDF Full Text HTML DOI: 10.17352/2455-3484.000062
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat

    Indexing/Archiving

    Pinterest on JAMTS